SUBSCRIBE
SUBSCRIBE
News   Policy

GlaxoSmithKline Said to Pay $250 Million to Resolve Avandia Suits

February 8, 2011 | 
1 min read
Philadelphia Business Journal -- GlaxoSmithKline has settled 5,500 cases related to its diabetes drug Avandia for $250 million, or an average of $46,000 each, the Philadelphia Inquirer reports in a Bloomberg story.
Legal
GSK
MORE ON THIS TOPIC
German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Businessman navigating his career path to success. The man and maze are on a separate labeled layer from the background.
Job Trends
As H-1B visa changes keep coming, biopharmas adjust hiring approach
October 22, 2026
 · 
5 min read
 · 
Angela Gabriel
Businessman standing on big megaphone. concept of business communication, skill to communicate with employee, send important message or announcement
Legal
‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma ban
October 14, 2026
 · 
4 min read
 · 
Annalee Armstrong
Blue holographic globe with nodes connected around earth. Concept of global network connection, communication technology, fintech, data exchange, worldwide exchange of information and online banking.
Manufacturing
Merck barred from making subcutaneous Keytruda in 8 European countries
October 8, 2026
 · 
2 min read
 · 
Nick Paul Taylor